Cargando…
Complement-mediated tumor cell damage induced by antibodies against membrane cofactor protein (MCP, CD46)
We have developed polyclonal and monoclonal antibodies against human membrane cofactor protein (MCP) to use as tools to investigate the functions of MCP on intact nucleated cells. Two human T cell lines, CEM and TALL, are CR1- and DAF-. Pretreatment of these cell lines with M177 and polyclonal anti-...
Formato: | Texto |
---|---|
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
1990
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2188751/ https://www.ncbi.nlm.nih.gov/pubmed/2258699 |
Ejemplares similares
-
Expression of membrane cofactor protein (MCP, CD46) in human liver diseases
por: Kinugasa, N, et al.
Publicado: (1999) -
Membrane cofactor protein (MCP; CD46): deficiency states and pathogen connections
por: Liszewski, M Kathryn, et al.
Publicado: (2021) -
Membrane cofactor protein (CD46) protects cells from complement- mediated attack by an intrinsic mechanism
Publicado: (1992) -
Genetic Analysis of Membrane Cofactor Protein (CD46) of the Complement System in Women with and without Preeclamptic Pregnancies
por: Lokki, A. Inkeri, et al.
Publicado: (2015) -
Correction: Genetic Analysis of Membrane Cofactor Protein (CD46) of the Complement System in Women with and without Preeclamptic Pregnancies
Publicado: (2015)